Cardiovascular

Heart Failure Drug Prevents Renal Damage?

Source: American College of Cardiology, Society for Cardiovascular Angiography and Interventions; March 29-April 1, 2008
Barry Massie
Barry Massie

Barry Massie, San Francisco VA Medical Center
COMMENT: Aaron Kugelmass, Henry Ford Hospital, Detroit
The adenosine A1-receptor antagonist rolofylline appears to prevent renal impairment and improve acute heart failure symptoms. Barry Massie and Aaron Kugelmass discussed findings from the 300-patient PROTECT pilot study with Sara Freeman.

Download this interview

Similar Interviews

  • Human Growth Hormone: Responses in Severe Heart Failure
  • Catherine Demers Recombinent human growth hormone has achieved clinical responses when used for treating heart failure. Catherine Demers of McMaster University

  • BNP Test: Key Diagnostic Step for Heart Failure (PEP Study)
  • John Cleland Maarten Simoons REFERENCE: Hot Line 1 Sunday 11:00 2 Sept, European Society of Cardiology

  • Levosimendan Improves Heart Failure Progression
  • Milton Packer In the REVIVE trial the inotropic agent levosimendan has improved short-term outcome in acutely decompensated heart failure. Milton Packer

    Post a comment